<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01112202</url>
  </required_header>
  <id_info>
    <org_study_id>Dabi2010</org_study_id>
    <nct_id>NCT01112202</nct_id>
  </id_info>
  <brief_title>Effect of Dabigatran on Coagulation parameters-an ex Vivo Study</brief_title>
  <official_title>Effect of Dabigatran on Coagulation Parameters in Patients Undergoing Elective Orthopaedic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dabigatran represent a new class of promising anticoagulation agents. As an oral direct
      thrombin inhibitor it has been effective in preventing venous thromboembolism in patients
      undergoing elective orthopaedic surgery. This ex vivo study is undertaken to investigate the
      ex-vivo effects of PradaxaÂ® on different coagulation parameters.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This mono-centric, open-label study is undertaken to validate the effects of Dabigatran on
      coagulation parameters in plasma samples of 70 patients after hip or knee replacement surgery
      treated with Dabigatran 150-220 mg/d. Plasma samples are obtained by blood collection before,
      after 2 hours and after 12-14 hours after Dabigatran dosing in steady state (on 3rd - 5th
      day).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Effect of Dabigatran in Laboratory Coagulation Parameters</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients after hip or knee replacement surgery treated with Dabigatran 150-220 mg/d
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 y

        Exclusion Criteria:

          -  Hemorrhagic disorder

          -  Liver disease

          -  Anemia

          -  Severe renal impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Johann Wolfgang Goethe University Hospital</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2010</study_first_submitted>
  <study_first_submitted_qc>April 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 28, 2010</study_first_posted>
  <last_update_submitted>June 5, 2012</last_update_submitted>
  <last_update_submitted_qc>June 5, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2012</last_update_posted>
  <responsible_party>
    <name_title>Prof. Edelgard Lindhoff-Last</name_title>
    <organization>Department of Vascular Medicine, University Hospital Frankfurt</organization>
  </responsible_party>
  <keyword>direct thrombin inhibitors</keyword>
  <keyword>Dabigatran</keyword>
  <keyword>Coagulation parameters</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dabigatran</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

